Rakesh Heer

Cancer Research UK, Freeman Hospital

Papers

3

Total Citations

31

H-Index

3

About

Rakesh Heer is a leading urological surgeon and researcher whose work has fundamentally shaped the modern surgical management of prostate and renal cancers. His primary research areas center on the comparative effectiveness of minimally-invasive surgical techniques, particularly laparoscopic and robot-assisted approaches. Heer’s major contribution is his rigorous, evidence-based evaluation of surgical innovation. His landmark 2011 critical systematic review, which has garnered 13 citations, provided a pivotal analysis of clinical trials comparing open, laparoscopic, and robot-assisted radical prostatectomy, helping to define the standards and outcomes for prostate cancer surgery. He has further advanced the field through his work on prostate cancer diagnosis, authoring a key 2022 review on biopsy approaches (12 citations) that guides current best practices in tissue sampling and risk stratification. Heer has also championed the adoption of laparoscopic renal surgery, demonstrating its superiority over open approaches. With a career dedicated to high-impact clinical research, Heer is a respected authority whose systematic evaluations have directly influenced surgical protocols and improved patient outcomes in urologic oncology.

Research Focus

Key Achievements

3
H-Index
3
Papers
31
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
A Critical Systematic Review of Recent Clinical Trials Comparing Open Retropubic, Laparoscopic and Robot-Assisted Laparoscopic Radical Prostatectomy
13 citations · 2011
📈 Most Prolific Year: 2011 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: Cancer Research UK, Freeman Hospital

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago